ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)

CAPS Rating: 2 out of 5

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

Recs

0
Player Avatar pchop123 (79.61) Submitted: 12/4/2012 10:09:06 AM : Underperform Start Price: $5.14 ACAD Score: +4.85

Lots of downside risk here in the short term especially after the big spike up

Featured Broker Partners


Advertisement